Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Morgan Stanley's stake in Praxis Precision Medicines, Inc. fell to 2.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 7, 2025
Morgan Stanley's stake in Praxis Precision Medicines, Inc. fell to 2.90%, 617,980 shares, as a passive investor on Sep 30, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 617,980
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 2.90% | 617,980 |
| Morgan Stanley Capital Services LLC | 1.40% | 296,731 |
Source
Related
- Praxis Precision Medicines, Inc.
- Morgan Stanley
- Praxis Precision Medicines, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 5, 2025
- Schedule 13G/A · Orbis Investment Management LTD · Aug 14, 2026
- Form 4 · Souza Marcio · Jul 8, 2026
- Form 4 · DeSimone Jill · Jun 26, 2026
- Form 4 · Arbuckle Stuart A · Jun 12, 2026
- Form 4 · Chodakewitz Jeffrey · Jun 12, 2026